The Second Wave of German Cannabis

Looking back to March 2017, the global cannabis industry was fixed on Germany. The 'Cannabis as Medicine' law came into force and the forecast of 800,000 potential cannabis patients in Germany was circulating. This led to Canadian cannabis companies, already in a stock frenzy, sensing their opportunity in the German market. More than seven years later, some of those former dreams have shattered, as economic reality did not meet the ambitious expectations. But since April 1, 2024, hopes are high once again and this time the signs are completely different. Many cannabis companies have now learned their lessons from previous years and are already preparing for profitability.

Ten years ago, hardly anyone would have envisaged that the rather conservative Germany at the heart of the European Union (EU) would initiate a paradigm shift in the regulation of cannabis. While the advent of the era of medical cannabis was forced through legal means in 2017, the new change is of a political nature, democratically mandated by the people. Additionally, even if the main goal, the legalized and commercial value chain for adult-use cannabis, has not materialized, the signs still point towards growth. This is also due to the last few years of the growing medical cannabis market.

Read more at krautinvest.de